|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
2-1 Kojimachi, Chiyoda-ku,Tokyo,Tokyo,JP
|
|
Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaRĀ® technology and structure-based drug design platform capabilities. The Company is advancing a broad and deep pipeline of partnered and wholly owned product candidates in multiple therapeutic areas, including CNS, cancer, metabolic diseases and other rare/specialty indications. Our partners and collaborators include AstraZeneca, Allergan, Pfizer, Daiichi-Sankyo, PeptiDream, Kymab, MorphoSys and Novartis. The Company is headquartered in Japan with R&D facilities in the UK.Sosei Heptares is the corporate brand of Sosei Group Corpoation, which is listed on the Tokyo Stock Exchange (ticker: 4565). For more information, please visit www.soseiheptares.com
|
Sosei Heptares Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
75%
|
The widely used Sosei Heptares email format is {first}.{last} (e.g. [email protected]) with 75% adoption across the company.
To contact Sosei Heptares customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.